MarketScreener Editorial Features Active Biotech AB Xetra
Equities
BTPC
SE0001137985
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Jul. 01 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
May. 22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
- Stock Market
- Equities
- ACTI Stock
- BTPC Stock
- News Active Biotech AB
- MarketScreener Editorial Features